Earnings

  • A sign for Zimmer Biomet is shown outside of the company's headquarters building.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Zimmer Biomet CFO departs for new job

    Suketu Upadhyay is headed to biopharma company Incyte. Paul Stellato will step into the CFO role on an interim basis.

    By • April 28, 2026
  • A corporate building for Edwards Lifesciences.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards raises 2026 forecast as TAVR sales surge

    The stronger outlook follows mixed results from other major medical device makers in the latest quarter, after both Abbott and Boston Scientific cut their full-year guidance.

    By • April 24, 2026
  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific slashes 2026 guidance

    CEO Mike Mahoney told investors that the lowered forecast reflects challenges for several businesses, including electrophysiology and Watchman.

    By • April 22, 2026
  • A modern office building with large reflective glass windows is shown behind a wide driveway and landscaped entrance. In the foreground, a white and orange monument sign reads "Intuitive Surgical" with the number "1020" vertically on the side.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Intuitive Surgical lifts 2026 outlook for da Vinci robot procedure growth

    The company, whose shares climbed nearly 8% Wednesday morning, also said a recent cyber incident has been contained and did not significantly affect first-quarter results.

    By • April 22, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    MiniMed posts double-digit sales growth, widening net loss

    New glucose sensors and a partnership with Abbott are expected to drive sales growth at MiniMed, BTIG analyst Marie Thibault wrote.

    By • April 21, 2026
  • A person wearing goggles and holding a clipboard looks at a tray in a laboratory.
    Image attribution tooltip
    Courtesy of Exact Sciences
    Image attribution tooltip

    Abbott lowers earnings forecast after $21B Exact Sciences buy

    CEO Robert Ford said the companies are a good cultural fit and he expects demand for Exact’s colon cancer screening test to increase.

    By • April 16, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s cardiovascular unit stands out again in Q1

    Johnson & Johnson’s strategic shift to higher growth medical device markets like cardiovascular is paying off, as the business was the only medtech unit to grow by double digits in the first quarter.

    By • April 14, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    Medtronic lowers earnings forecast after MiniMed IPO

    The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results for its 2026 fiscal year.

    By • March 25, 2026
  • A lab technician runs Guardant Health's Shield blood test for colorectal cancer screening in a lab.
    Image attribution tooltip
    Courtesy of Business Wire
    Image attribution tooltip

    Guardant buys MetaSight for $59M upfront to acquire blood test tech

    MetaSight uses metabolomics, lipidomics and proteomics mass spectrometry technologies to develop tests for specific diseases, including conditions outside of oncology.

    By • Feb. 23, 2026
  • Two people view Medtronic's Hugo robotic surgery system in an operating room.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic completes first Hugo case in the US

    CEO Geoff Martha said that while Hugo may not “move the needle” for Medtronic’s surgical business yet, the system is growing “pretty fast.”

    By • Feb. 17, 2026
  • Professional photo of Jake Leach
    Image attribution tooltip
    Permission granted by Dexcom
    Image attribution tooltip

    Dexcom seeks expanded Medicare coverage of CGMs for Type 2 diabetes

    New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.

    By • Feb. 13, 2026
  • Professional photo of Ivan Tornos
    Image attribution tooltip
    Permission granted by Zimmer Biomet
    Image attribution tooltip

    Zimmer plans US salesforce reorganization

    Zimmer Biomet expects the shift of its U.S. salesforce to a more specialized, direct approach will help it better compete in the orthopedics market.

    By • Feb. 11, 2026
  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards focuses on earlier TAVR adoption

    The heart valve specialist reported a second straight quarter of double-digit TAVR sales growth and credited recent study results with driving a “sense of urgency” for treating patients.

    By • Feb. 11, 2026
  • Shipping containers of varying colors stacked on a ship.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    GE HealthCare expects smaller tariff impact in 2026

    After taking a $245 million hit from the levies in 2025, CFO James Saccaro said the company plans more actions to mitigate their effects in 2026, including shifting its supply chain.

    By • Feb. 5, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific continues to see electrophysiology success despite slowdown in growth

    Pulsed field ablation has fueled strong sales growth for the firm’s electrophysiology business over the past two years. However, the pace has slowed in recent quarters.

    By • Feb. 4, 2026
  • Four robots side by side with a single arm have different instruments attached to the end.
    Image attribution tooltip
    Courtesy of Stryker
    Image attribution tooltip

    Stryker starts first cases with handheld ortho robot

    Stryker expects the robot, called Mako RPS, to bring in new customers, including more ambulatory surgery centers.

    By • Jan. 30, 2026
  • A surgeon sits at the console of a da Vinci 5 robot while another medical professional works in the background.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip

    Intuitive pushes into cardiac robotic surgery, ASCs

    The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping up its presence in ambulatory surgery centers.

    By • Jan. 23, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott posts Q4 sales below expectations

    Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the company’s shares.

    By • Jan. 22, 2026
  • A wall bearing the Johnson & Johnson logo is seen outside of an office building.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J’s cardiovascular business boosts medtech growth in 2025

    Cardiovascular was the only business unit to grow by double digits last year, helping to fuel the overall medical device business to top $33 billion.

    By • Jan. 21, 2026
  • Intuitive Surgical's da Vinci 5 robotic surgery system is shown against a white background.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip

    Intuitive says general surgery, acute care fuel US robot momentum

    CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving greater utilization than the earlier Xi model.

    By • Jan. 16, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic’s PFA business is heating up

    Pulsed field ablation sales grew by more than 300% in the second quarter for the company’s 2026 fiscal year, amid mounting competition in the space.

    By • Nov. 18, 2025
  • Vicarious Surgical's robotic system.
    Image attribution tooltip
    Courtesy of Vicarious Surgical
    Image attribution tooltip

    Vicarious says it will outsource some robot development functions

    The initiative is part of a restructuring to preserve cash while the company completes the design of the robotic surgery system it plans to commercialize.

    By • Nov. 14, 2025
  • A picture of MMI's Symani robotic surgery system.
    Image attribution tooltip
    Courtesy of MMI
    Image attribution tooltip

    MMI tackles Alzheimer’s; SS Innovations advances telesurgery

    MMI won FDA approval to study robotic surgery for Alzheimer’s disease. Elsewhere, SS Innovations’ CEO performed remote bypass surgery with a new console, and Procept BioRobotics’ Q3 revenue rose 43%.

    By • Nov. 10, 2025
  • The entrance to Illumina's San Diego campus.
    Image attribution tooltip
    Courtesy of Illumina
    Image attribution tooltip

    Illumina says China is lifting export ban

    However, the sequencing company said it remains on China’s unreliable entity list, and it is working toward a long-term resolution of the issue.

    By • Nov. 6, 2025
  • A picture of Siemens Healthineers' headquarters building in Erlangen, Germany.
    Image attribution tooltip
    Courtesy of Siemens Healthineers
    Image attribution tooltip

    Siemens Healthineers predicts tariff impact will double

    The company expects to fully offset the negative effects of tariffs in the medium term.

    By • Nov. 6, 2025